companydata.dkcompanydata.dk

C4PAIN ApS: Financial statements 2016

CVR: 32292402

Source: annual report 2016, Danish Business Authority

01/01/201631/12/2016

C4PAIN ApS (CVR 32292402) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -453,434 and a net result of DKK -373,938 compared with DKK -234,519 the year before. Equity in the 2016 report amounted to DKK 152,155. The solvency ratio was 9.9%.

Gross Profit
DKK -453,434
Profit/Loss
DKK -373,938
Equity
DKK 152,155
Total Assets
DKK 1,533,071

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016--453 t.-374 t.152 t.-
2015--405 t.-235 t.526 t.-
2014-285 t.241 t.761 t.-
2013--448 t.1.6 mio.520 t.-
2012-2.1 mio.-386 t.2.7 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like C4PAIN ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2016

C4PAIN ApS: The 2015 annual report is outMay 31, 2016

C4PAIN ApS has published its annual report for 2015. Gross profit came to DKK -404,558, and the net result was DKK -234,519.

C4PAIN ApS appoints new auditorMay 2, 2016

As of May 2, 2016, REDMARK, GODKENDT REVISIONSPARTNERSELSKAB has been appointed auditor of C4PAIN ApS.

Auditor steps down at C4PAIN ApSMay 2, 2016

As of May 2, 2016, REVISIONSFIRMAET PETER KRISTENSEN has stepped down as auditor of C4PAIN ApS.

Lars Arendt-Nielsen joins C4PAIN ApS as adm. dir.May 2, 2016

As of May 2, 2016, Lars Arendt-Nielsen is registered as adm. dir. of C4PAIN ApS.

Hans Christian Hoeck steps down as adm. dir. of C4PAIN ApSMay 2, 2016

As of May 2, 2016, Hans Christian Hoeck has stepped down as adm. dir. of C4PAIN ApS.

About C4PAIN ApS

C4PAIN ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lars Arendt-Nielsen. The company is owned by BIO-MEDICAL CONSULT HOLDING ApS. The company has 0 employees (2014). In 2025, the company reported a gross profit of DKK 159,243 and a net result of DKK 185,909 compared with DKK 1,074,600 the year before. Equity in the 2025 report amounted to DKK 4,164,765.

Source: annual report 2025, Danish Business Authority